The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …
This new report from Venture Planning Group provides leading chemical companies marketing tactics. The analysis presents:
- Major promotional strategies.
- Distribution approaches.
- Product service and support.
The companies analyzed in the report include BASF, Dow, DuPont, ExxonMobil, INEOS, Lyondell, Mitsubishi Chemical, SABIC, Shell, and Sinopec.